MEDIA RELEASE PR36415
AlphaHelix Presents AmpXpress(TM) at the BIOTECHNICA Show
UPPSALA, Oct. 6 /PRNewswire-AsiaNet/ --
- A New Miniaturized PCR Instrument With SuperConvection(TM)
- At One Sixth the Price of QuanTyper(TM) Without Loss of Performance
- Next Generation of PCR Expected to Rapidly Penetrate the Market
AlphaHelix (Ticker: ALPH) has in a very short time developed a miniaturized PCR-instrument - AmpXpress(TM) -
to meet demands for lower instrument prices. This was made possible through know-how obtained during the
development of QuanTyper(TM). AmpXpress(TM) is substantially smaller in size and weight, silent, consumes less
power and will attract customers that are looking for a fast, simple and easy to use PCR-instrument with
SuperConvection(TM). AlphaHelix expects a rapid penetration of the market as the price of AmpXpress(TM) is
comparable to low-end thermal cyclers (without a rotary format). The sales price of AmpXpress(TM) is only one
sixth of the price of QuanTyper(TM) (the first version of AmpXpress(TM) is however a standard PCR instrument,
and does not feature real-time detection (qPCR). AmpXpress(TM) will be presented tomorrow at the
BIOTECHNICA show in Hannover, Germany.
cost approximately 500 KSEK (gross). AlphaHelix has also been granted 250 KSEK by the Swedish Agency for
Economic and Regional Growth. A first series of ten instruments has been initiated and patent applications have
been submitted.
Technology assessment of SuperConvection and QuanTyper(TM) proceeds at the American biotechnology
company and is not affected by the launch of AmpXpress(TM). Results from the evaluation are expected early
November, at the earliest.
AlphaHelix Molecular Diagnostics AB (publ) develops instruments for rapid DNA analysis. The company's
patented technology enables identification of virus and bacteria faster and with greater sensitivity than other
is a multilateral trading facility for small caps under the supervision of the Swedish Financial Supervisory Authority.
SOURCE: Alpha Helix Molecular Diagnostics AB
NEWS 
